Vaxcyte, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$923.7 | -$569.5 | -$468.0 | -$232.3 | -$103.7 |
| Net income | -$766.6 | -$463.9 | -$402.3 | -$223.5 | -$100.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$669.3 | -$475.1 | -$312.9 | -$176.4 | -$127.9 |
Shares outstanding 144.4M · Free float 94.8%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.